首页 | 本学科首页   官方微博 | 高级检索  
     


Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
Authors:Yanwen Jiang  David Redmond  Kui Nie  Ken W Eng  Thomas Clozel  Peter Martin  Leonard HC Tan  Ari M Melnick  Wayne Tam  Olivier Elemento
Affiliation:.Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021 USA ;.Department of Medicine, Weill Cornell Medical College, New York, NY 10021 USA ;.Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10021 USA ;.Hematology, Lymphoid Unit, Hôpital Henri Mondor, Creteil, 94010 France ;.Department of Pathology, Singapore General Hospital, Singapore, 169608 Singapore
Abstract:

Background

Molecular mechanisms associated with frequent relapse of diffuse large B-cell lymphoma (DLBCL) are poorly defined. It is especially unclear how primary tumor clonal heterogeneity contributes to relapse. Here, we explore unique features of B-cell lymphomas - VDJ recombination and somatic hypermutation - to address this question.

Results

We performed high-throughput sequencing of rearranged VDJ junctions in 14 pairs of matched diagnosis-relapse tumors, among which 7 pairs were further characterized by exome sequencing. We identify two distinctive modes of clonal evolution of DLBCL relapse: an early-divergent mode in which clonally related diagnosis and relapse tumors diverged early and developed in parallel; and a late-divergent mode in which relapse tumors developed directly from diagnosis tumors with minor divergence. By examining mutation patterns in the context of phylogenetic information provided by VDJ junctions, we identified mutations in epigenetic modifiers such as KMT2D as potential early driving events in lymphomagenesis and immune escape alterations as relapse-associated events.

Conclusions

Altogether, our study for the first time provides important evidence that DLBCL relapse may result from multiple, distinct tumor evolutionary mechanisms, providing rationale for therapies for each mechanism. Moreover, this study highlights the urgent need to understand the driving roles of epigenetic modifier mutations in lymphomagenesis, and immune surveillance factor genetic lesions in relapse.

Electronic supplementary material

The online version of this article (doi:10.1186/s13059-014-0432-0) contains supplementary material, which is available to authorized users.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号